WP
HUMA icon

Woodline Partners’s Humacyte HUMA Stock Holding History

Woodline Partners’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$391K Sell
500,582
-1,502,000
-75% -$1.39M ﹤0.01% 984
2026
Q1 		$1.21M Buy
2,002,582
+509
+0% +$529 ﹤0.01% 859
2025
Q4 		$1.92M Hold
2,002,073
– – 0.01% 772
2025
Q3 		$3.48M Buy
2,002,073
+680
+0% +$1.33K 0.02% 639
2025
Q2 		$4.18M Sell
2,001,393
-1,948,607
-49% -$3.74M 0.02% 598
2025
Q1 		$6.73M Buy
3,950,000
+1,101,198
+39% +$4.13M 0.04% 433
2024
Q4 		$14.4M Buy
2,848,802
+2,000,268
+236% +$9.9M 0.1% 273
2024
Q3 		$4.62M Buy
+848,534
New +$5.59M 0.04% 395

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Woodline Partners's HUMA Position: Q2 2026 in Review

Woodline Partners reduced its Humacyte (HUMA) stake by 75% in Q2 2026, selling an estimated $1.39M and leaving 500,582 shares worth $391K. The position accounts for ﹤0.01% of the portfolio, ranked #984.

Woodline Partners first reported a position in HUMA in Q3 2024 and has held it in 8 quarters since. The position peaked at $14.4M in Q4 2024. 164 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Woodline Partners held 500,582 shares of Humacyte worth $391K as of Q2 2026.
  • Woodline Partners sold 1,502,000 Humacyte shares in Q2 2026, an estimated $1.39M.
  • Humacyte made up ﹤0.01% of Woodline Partners's portfolio in Q2 2026, its #984 holding.
  • Woodline Partners first reported a position in Humacyte in Q3 2024 and has held it in 8 quarters since.
  • Woodline Partners's Humacyte position peaked at $14.4M in Q4 2024.
  • 164 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.